Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
DNA methylation is the major modification of eukaryotic genomes and plays an essential role in mammalian development. Additionally we are shipping MBD2 Antibodies (103) and and many more products for this protein.
Specifically, methyl-CpG-binding domain protein 2 (MBD2) is revealed to be recruited to DNA damage sites after laser microirradiation, which was mediated through MBD (show DPEP1 ELISA Kits) domain and MBD2 (show DPEP2 ELISA Kits) C-terminus.
MBD2 targets short interspersed nuclear elements, but does not exclude RNA Polymerase III.
The dynamics of MBD2 (show DPEP2 ELISA Kits) deposition across methylated DNA regions was associated with the oncogenic transformation of human mammary cells.
Data suggest that MBD2 (show DPEP2 ELISA Kits) binds primarily at highly methylated regions, with a strong preference for CpG islands and highlights that MBD2 (show DPEP2 ELISA Kits) binding sites display increased methylation in primary breast cancer tissues as compared to normal mammary cells.
Biophysical analyses show that the MBD2IDR is an intrinsically disordered region (IDR). However, despite this inherent disorder, MBD2IDR increases the overall binding affinity of MBD2 (show DPEP2 ELISA Kits) for methylated DNA.
This study investigates the genetic association between methyl-CpG-binding domain (MBD (show DPEP1 ELISA Kits)) gene polymorphisms and schizophrenia.
The methylated-DNA binding protein (show UBE2V1 ELISA Kits) MBD2 (show DPEP2 ELISA Kits) enhances NGFI-A (egr-1 (show EGR1 ELISA Kits))-mediated transcriptional activation of the glucocorticoid receptor (show NR3C1 ELISA Kits).
These data point to a potential new approach in targeting the DNA methylation (show HELLS ELISA Kits) machinery by combination of MBD2 (show DPEP2 ELISA Kits) and DNMT (show DNMT1 ELISA Kits) inhibitors.
MBD2 (show DPEP2 ELISA Kits) seems to play a selective role in gene repression depending on the CpG content of the promoter region
Methylated DNA binding domain protein 2 (MBD2 (show DPEP2 ELISA Kits)) coordinately silences gene expression through activation of the microRNA hsa (show CD24 ELISA Kits)-mir (show MLXIP ELISA Kits)-496 promoter in breast cancer cell line.
Mbd2 has a key role regulating expression of a range of genes that are associated with optimal dendritic cell activation and function.
methyl-CpG-binding domain protein 2 (MBD2), an epigenetic regulator, controls autoimmunity and EAE through T-bet/Hlx (show HLX ELISA Kits).
Biophysical analyses show that the MBD2IDR is an intrinsically disordered region (IDR). However, despite this inherent disorder, MBD2IDR increases the overall binding affinity of MBD2 for methylated DNA.
miR (show MLXIP ELISA Kits)-290/371-Mbd2-Myc (show MYC ELISA Kits) circuit regulates glycolytic metabolism to promote pluripotency.
these findings suggest that CpG methylation and MBD2 are involved in altering Scn3a (show SCN3A ELISA Kits) expression during postnatal development and seizure condition.
Data suggest that methyl-CpG binding domain protein 2 (MBD2) gene knockout may lead to accumulation of more deposits on the Bruch's membrane (BM) and influence the pathogenesis of age-related macular degeneration (AMD (show AMD1 ELISA Kits)).
In metastatic colorectal cancer cells, reduced levels of miR (show MLXIP ELISA Kits)-221* and miR (show MLXIP ELISA Kits)-224 increase levels of MBD2, thereby decreasing expression of the metastasis suppressor maspin (show SERPINB5 ELISA Kits).
Mbd2 has a key role in promoting the Treg-specific demethylation region demethylation, Foxp3 (show FOXP3 ELISA Kits) expression, and Treg-suppressive function.
Our results strengthen the possibility that MeCP2 (show MECP2 ELISA Kits) and MBD2 direct interactions could crosslink chromatin fibers and therefore give novel insight into the molecular mechanism of MBD (show DPEP1 ELISA Kits) mediated global heterochromatin architecture.
DNA methylation is the major modification of eukaryotic genomes and plays an essential role in mammalian development. Human proteins MECP2, MBD1, MBD2, MBD3, and MBD4 comprise a family of nuclear proteins related by the presence in each of a methyl-CpG binding domain (MBD). Each of these proteins, with the exception of MBD3, is capable of binding specifically to methylated DNA. MECP2, MBD1 and MBD2 can also repress transcription from methylated gene promoters. The protein encoded by this gene may function as a mediator of the biological consequences of the methylation signal. It is also reported that the this protein functions as a demethylase to activate transcription, as DNA methylation causes gene silencing. Two transcript variants encoding different isoforms have been found for this gene.
methyl-CpG binding domain protein 2
, methyl-CpG-binding domain protein 2
, methyl-CpG-binding protein MBD2
, methyl-CpG binding protein MBD2